An α-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen

Tamoxifen (Tam) is effective for the treatment and prevention of breast cancer. However, it has toxic drawbacks and has limited-duration utility because, over time, human tumours become refractory to Tam. Recently, a new nontoxic peptide, α-fetoprotein-derived peptide (AFPep) has been proposed for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, T T, Georgekutty, J, DeFreest, L A, Amaratunga, G, Narendran, A, Lemanski, N, Jacobson, H I, Bennett, J A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360332/
https://www.ncbi.nlm.nih.gov/pubmed/17637684
http://dx.doi.org/10.1038/sj.bjc.6603882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360332/
https://www.ncbi.nlm.nih.gov/pubmed/17637684
http://dx.doi.org/10.1038/sj.bjc.6603882

Ejemplares similares